Titan Biotech Limited (TITANBIO.BO)
INR 456.8
(-0.87%)
INR 456.8
(-0.87%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 117.05 Million INR | -35.45% |
| 2022 | 472.07 Million INR | 19.59% |
| 2021 | 394.75 Million INR | 74.83% |
| 2020 | 225.79 Million INR | 12.56% |
| 2019 | 200.6 Million INR | 17.03% |
| 2018 | 171.41 Million INR | 33.29% |
| 2017 | 128.59 Million INR | 63.17% |
| 2016 | 78.81 Million INR | -9.16% |
| 2015 | 86.76 Million INR | 21.02% |
| 2014 | 71.69 Million INR | 10.06% |
| 2013 | 65.14 Million INR | 33.87% |
| 2012 | 48.66 Million INR | 23.79% |
| 2011 | 39.3 Million INR | -16.79% |
| 2010 | 47.23 Million INR | 116.15% |
| 2009 | 21.85 Million INR | 30.06% |
| 2008 | 16.8 Million INR | -35.28% |
| 2007 | 25.96 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 68.27 Million INR | -11.91% |
| 2023 Q2 | 143.51 Million INR | 9.64% |
| 2023 Q1 | 130.9 Million INR | -1.92% |
| 2023 Q4 | 77.5 Million INR | -47.2% |
| 2023 FY | 304.74 Million INR | -35.45% |
| 2023 Q3 | 146.79 Million INR | 2.29% |
| 2022 Q3 | 129.09 Million INR | 21.18% |
| 2022 Q4 | 133.46 Million INR | 3.38% |
| 2022 FY | 472.07 Million INR | 19.59% |
| 2022 Q1 | 102.97 Million INR | 2477.21% |
| 2022 Q2 | 106.53 Million INR | 3.46% |
| 2021 Q1 | 82.96 Million INR | 975.05% |
| 2021 FY | 394.75 Million INR | 74.83% |
| 2021 Q2 | 102.66 Million INR | 23.75% |
| 2021 Q3 | 97.24 Million INR | -5.28% |
| 2021 Q4 | 3.99 Million INR | -95.89% |
| 2020 FY | 225.79 Million INR | 12.56% |
| 2020 Q2 | 80.21 Million INR | 6.12% |
| 2020 Q3 | 84.97 Million INR | 5.93% |
| 2020 Q4 | -9.48 Million INR | -111.16% |
| 2020 Q1 | 75.59 Million INR | 7699.39% |
| 2019 FY | 200.6 Million INR | 17.03% |
| 2019 Q1 | 61.99 Million INR | -14.19% |
| 2019 Q2 | 69.41 Million INR | 11.96% |
| 2019 Q3 | 70.61 Million INR | 1.72% |
| 2019 Q4 | -994.71 Thousand INR | -101.41% |
| 2018 Q3 | 54.1 Million INR | -20.85% |
| 2018 Q4 | 72.25 Million INR | 33.54% |
| 2018 Q2 | 68.35 Million INR | 8.99% |
| 2018 Q1 | 62.71 Million INR | 128.64% |
| 2018 FY | 171.41 Million INR | 33.29% |
| 2017 Q3 | 28.44 Million INR | -3.15% |
| 2017 FY | 128.59 Million INR | 63.17% |
| 2017 Q4 | 27.43 Million INR | -3.57% |
| 2017 Q2 | 29.37 Million INR | 8.74% |
| 2017 Q1 | 27.01 Million INR | 0.76% |
| 2016 Q4 | 26.81 Million INR | -28.58% |
| 2016 FY | 78.81 Million INR | -9.16% |
| 2016 Q1 | 21.71 Million INR | 372.13% |
| 2016 Q3 | 37.54 Million INR | 5.08% |
| 2016 Q2 | 35.72 Million INR | 64.54% |
| 2015 FY | 86.76 Million INR | 21.02% |
| 2015 Q4 | -7.97 Million INR | -123.88% |
| 2015 Q3 | 33.41 Million INR | -1.58% |
| 2015 Q2 | 33.95 Million INR | 25.06% |
| 2015 Q1 | 27.14 Million INR | 300.28% |
| 2014 Q1 | 24.35 Million INR | 305.1% |
| 2014 FY | 71.69 Million INR | 10.06% |
| 2014 Q3 | 32.76 Million INR | 16.03% |
| 2014 Q2 | 28.23 Million INR | 15.92% |
| 2014 Q4 | -13.55 Million INR | -141.37% |
| 2013 Q2 | 28.54 Million INR | 58.45% |
| 2013 Q4 | -11.87 Million INR | -140.74% |
| 2013 Q1 | 18.01 Million INR | 8215.61% |
| 2013 Q3 | 29.15 Million INR | 2.12% |
| 2013 FY | 65.14 Million INR | 33.87% |
| 2012 Q4 | -221.99 Thousand INR | -101.24% |
| 2012 Q1 | 14.34 Million INR | -4.46% |
| 2012 Q2 | 16.62 Million INR | 15.92% |
| 2012 Q3 | 17.91 Million INR | 7.71% |
| 2012 FY | 48.66 Million INR | 23.79% |
| 2011 Q4 | 15.01 Million INR | 0.5% |
| 2011 Q3 | 14.93 Million INR | 0.0% |
| 2011 FY | 39.3 Million INR | -16.79% |
| 2010 Q4 | 12.17 Million INR | 0.0% |
| 2010 FY | 47.23 Million INR | 116.15% |
| 2009 FY | 21.85 Million INR | 30.06% |
| 2008 FY | 16.8 Million INR | -35.28% |
| 2008 Q4 | 10.36 Million INR | 0.0% |
| 2007 FY | 25.96 Million INR | 0.0% |
| 2007 Q4 | 7.94 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.24 Million INR | -9340.081% |
| Biocon Limited | 40.9 Billion INR | 99.714% |
| Blue Jet Healthcare Limited | 531.85 Million INR | 77.991% |
| Concord Biotech Limited | 1.45 Billion INR | 91.981% |
| Dishman Carbogen Amcis Limited | 5.14 Billion INR | 97.726% |
| FERMENTA BIOTECH LIMITED | 754.2 Million INR | 84.48% |
| GENOMIC VALLEY BIOTECH LIMITED | 375 Thousand INR | -31115.2% |
| Lyka Labs Limited | 599.4 Million INR | 80.471% |
| Panacea Biotec Limited | 1.99 Billion INR | 94.134% |
| SAMSRITA LABS LIMITED | 1.49 Million INR | -7717.454% |
| Servoteach Industries Limited | 785.00 INR | -14911619.745% |
| SMS Lifesciences India Limited | 602.96 Million INR | 80.586% |
| Supriya Lifescience Limited | 1.08 Billion INR | 89.163% |
| Syngene International Limited | 5.99 Billion INR | 98.047% |
| TAKE Solutions Limited | 396.91 Million INR | 70.508% |
| Transgene Biotek Limited | 5.39 Million INR | -2068.927% |
| Vanta Bioscience Limited | 38.95 Million INR | -200.47% |